Cargando…
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339084/ https://www.ncbi.nlm.nih.gov/pubmed/35917841 http://dx.doi.org/10.1016/j.jinf.2022.07.023 |
_version_ | 1784760100852858880 |
---|---|
author | Bojkova, Denisa Stack, Richard Rothenburger, Tamara Kandler, Joshua D. Ciesek, Sandra Wass, Mark N. Michaelis, Martin Cinatl, Jindrich |
author_facet | Bojkova, Denisa Stack, Richard Rothenburger, Tamara Kandler, Joshua D. Ciesek, Sandra Wass, Mark N. Michaelis, Martin Cinatl, Jindrich |
author_sort | Bojkova, Denisa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9339084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93390842022-08-01 Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants Bojkova, Denisa Stack, Richard Rothenburger, Tamara Kandler, Joshua D. Ciesek, Sandra Wass, Mark N. Michaelis, Martin Cinatl, Jindrich J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-11 2022-07-31 /pmc/articles/PMC9339084/ /pubmed/35917841 http://dx.doi.org/10.1016/j.jinf.2022.07.023 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Bojkova, Denisa Stack, Richard Rothenburger, Tamara Kandler, Joshua D. Ciesek, Sandra Wass, Mark N. Michaelis, Martin Cinatl, Jindrich Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants |
title | Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants |
title_full | Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants |
title_fullStr | Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants |
title_full_unstemmed | Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants |
title_short | Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants |
title_sort | synergism of interferon-beta with antiviral drugs against sars-cov-2 variants |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339084/ https://www.ncbi.nlm.nih.gov/pubmed/35917841 http://dx.doi.org/10.1016/j.jinf.2022.07.023 |
work_keys_str_mv | AT bojkovadenisa synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants AT stackrichard synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants AT rothenburgertamara synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants AT kandlerjoshuad synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants AT cieseksandra synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants AT wassmarkn synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants AT michaelismartin synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants AT cinatljindrich synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants |